Saccharomyces Cerevisiae Sepsis Following Probiotic Therapy in an Infant
Overview
Affiliations
A 3.5-month-old infant with undiagnosed underlying combined immunodeficiency presented with S. ceravisiae fungemia following treatment with S. boulardii containing probiotic preparation. This case highlights that the use of probiotics in sick patients may be fraught with danger.
Accounting for the health risk of probiotics.
Liu X, Zhao H, Wong A Heliyon. 2024; 10(6):e27908.
PMID: 38510031 PMC: 10950733. DOI: 10.1016/j.heliyon.2024.e27908.
Klepacka J, Zakrzewska Z, Czogala M, Wojtaszek-Glowka M, Krzysztofik E, Czogala W Int J Environ Res Public Health. 2022; 19(4).
PMID: 35206670 PMC: 8872470. DOI: 10.3390/ijerph19042485.
Probiotics: Should All Patients Take Them?.
Katkowska M, Garbacz K, Kusiak A Microorganisms. 2021; 9(12).
PMID: 34946221 PMC: 8706842. DOI: 10.3390/microorganisms9122620.
Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review.
DAgostin M, Squillaci D, Lazzerini M, Barbi E, Wijers L, Da Lozzo P Children (Basel). 2021; 8(10).
PMID: 34682189 PMC: 8534463. DOI: 10.3390/children8100924.
Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates ().
Imre A, Kovacs R, Pazmandi K, Nemes D, Jakab A, Fekete T J Fungi (Basel). 2021; 7(9).
PMID: 34575784 PMC: 8472476. DOI: 10.3390/jof7090746.